Document is current
Any future updates will be listed below
-
Authors
Kulkarni, Spoorthy
Faconti, Luca https://orcid.org/0000-0002-1066-6899
Partridge, Sarah https://orcid.org/0009-0005-8434-2896
Delles, Christian https://orcid.org/0000-0003-2238-2612
Glover, Mark
Lewis, Philip https://orcid.org/0000-0002-7903-390X
Gray, Asha
Hodson, Emma
Macintyre, Iain https://orcid.org/0000-0003-4420-3822
Maniero, Carmen
McEniery, Carmel M. https://orcid.org/0000-0003-3636-0705
Sinha, Manish D. https://orcid.org/0000-0001-7593-1203
Walsh, Stephen B.
Wilkinson, Ian B. https://orcid.org/0000-0001-6598-9399
- License Information
-
More Information
Article History
Received: 18 May 2024
Revised: 27 May 2024
Accepted: 5 June 2024
First Online: 28 June 2024
Competing interests
: Professor Adrian J.B. Brady has received honoraria from Daiichi-Sankyo, Amgen, Sanofi-Aventis, Bayer, MSD, and Novartis. Professor Phil Chowienczyk has an interest in Centron Diagnostics, a company that has produced technology for blood pressure measurement. Dr Jacob George has received grants and travel funding from Daiichi Sankyo, is on Advisory Boards for AstraZeneca and Novartis, and is a Principal Investigator for studies funded by AstraZeneca, Alnylam, Novartis, Esperion. Dr Pankaj Gupta has received research grants, lecture honoraria funding for conference attendance from Sanofi-Aventis and Amgen, and consulting fees from Ionis Pharmaceuticals. Dr Spoorthy Kulkarni is a PhD student at the University of Cambridge funded by AstraZeneca and has attended scientific advisory boards for Viatris. Dr Iain MacIntyre has received honoraria from AstraZeneca and is a Principal Investigator for studied funded by Alnylam Pharmaceuticals. Professor Terry McCormack has received lecture honoraria and/or consultation fees from Amarin, AstraZeneca, Bayer, Daichi-Sankyo, Medtronic, Novartis, OMRON and Sanofi-Aventis. Professor Neil R Poulter has received lecture honoraria and/or consultation fees from several pharmaceutical companies that manufacture blood pressure lowering agents including AstraZeneca, Eva Pharma, Lri Therapharma, Napi, Pfizer, Servier, and Sanofi-Aventis. Dr. Pauline Swift has received lecture honoraria from AstraZeneca, Boehringer-Ingelheim and Bayer. Professor Ian B Wilkinson has received research grants from AstraZeneca, GSK, and scientific advisory board consultation fees for Viatris, Astra Zeneca and Roche. Professor Christian Delles, Dr. Luca Faconti, Dr. Asha Gray, Dr. Emma Hodson, Dr. Andrew Jordan, Dr. Vikas Kapil, Dr. Philip Lewis, Dr. Carmen Maniero, Dr Carmel M McEniery, Professor Peter Sever, Dr. Manish B Sinha, Dr. James Sheppard, Dr. Wayne Sunman, Mr. Sam Olden, Dr. Sarah Partridge and Professor Stephen B Walsh have no competing interest to declare for this manuscript.
